- Home
- WDH vs NMRA Comparison
WDH vs NMRA Comparison
Compare WDH & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | WDH | NMRA |
|---|---|---|
| Founded | 2016 | 2019 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.7M | 554.0M |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | WDH | NMRA |
|---|---|---|
| Price | $1.68 | $2.23 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 207.4K | ★ 1.4M |
| Earning Date | 06-04-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.55% | N/A |
| EPS Growth | N/A | ★ 5.23 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.71 | N/A |
| P/E Ratio | $9.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.24 | $0.63 |
| 52 Week High | $2.18 | $3.65 |
Technical Indicators
Market Signals| Indicator | WDH | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 47.84 | 45.92 |
| Support Level | $1.65 | $1.79 |
| Resistance Level | $1.74 | $2.22 |
| Average True Range (ATR) | 0.05 | 0.16 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 40.00 | 51.00 |
Price Performance
Historical ComparisonAbout WDH Waterdrop Inc. (each representing the right to receive 10)
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.